Clorox (CLX) Shares Sink 15.2% as Sales and Cash Flow Woes Mount

Clorox (CLX) shares slumped 15.2% in the six months ended June 1, 2026, sharply underperforming the S&P 500’s 10.9% gain and leaving the stock at $90.24. Analysts cited three concerns that keep the stock off their buy list. The consumer products company posted annualized sales declines of 1.9% over the past three years. Even on an organic basis, year-on-year revenue growth averaged a tepid 1.9% over the last eight quarters, lagging the broader sector. Cash-flow pressures intensified as free cash flow margin contracted 5.8 percentage points year over year to 5.6%, signaling rising capital intensity. Though Clorox trades at 15.9 times forward earnings, analysts see no near-term catalyst and recommend rotating into a top digital advertising pick instead.